JPH053880B2 - - Google Patents
Info
- Publication number
- JPH053880B2 JPH053880B2 JP61500124A JP50012485A JPH053880B2 JP H053880 B2 JPH053880 B2 JP H053880B2 JP 61500124 A JP61500124 A JP 61500124A JP 50012485 A JP50012485 A JP 50012485A JP H053880 B2 JPH053880 B2 JP H053880B2
- Authority
- JP
- Japan
- Prior art keywords
- protease inhibitors
- protease
- administration
- serine protease
- inhibiting
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 108091005804 Peptidases Proteins 0.000 description 6
- 229940042399 direct acting antivirals protease inhibitors Drugs 0.000 description 5
- 239000000137 peptide hydrolase inhibitor Substances 0.000 description 5
- 102000035195 Peptidases Human genes 0.000 description 4
- 239000004365 Protease Substances 0.000 description 4
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 2
- 102000012479 Serine Proteases Human genes 0.000 description 2
- 108010022999 Serine Proteases Proteins 0.000 description 2
- 150000001413 amino acids Chemical group 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 229920001184 polypeptide Polymers 0.000 description 2
- 102000004196 processed proteins & peptides Human genes 0.000 description 2
- 108090000765 processed proteins & peptides Proteins 0.000 description 2
- 229940024999 proteolytic enzymes for treatment of wounds and ulcers Drugs 0.000 description 2
- 239000003001 serine protease inhibitor Substances 0.000 description 2
- 229940122055 Serine protease inhibitor Drugs 0.000 description 1
- 101710102218 Serine protease inhibitor Proteins 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- 239000012678 infectious agent Substances 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000007911 parenteral administration Methods 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000002797 proteolythic effect Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 238000011200 topical administration Methods 0.000 description 1
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/52—Improvements relating to the production of bulk chemicals using catalysts, e.g. selective catalysts
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Enzymes And Modification Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US67882384A | 1984-12-06 | 1984-12-06 | |
| US678823 | 1984-12-06 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS62501291A JPS62501291A (ja) | 1987-05-21 |
| JPH053880B2 true JPH053880B2 (OSRAM) | 1993-01-18 |
Family
ID=24724432
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP61500124A Granted JPS62501291A (ja) | 1984-12-06 | 1985-12-04 | 精製セリンプロテアーゼインヒビターおよびこれを含有する医薬組成物 |
| JP4166079A Expired - Lifetime JPH0717678B2 (ja) | 1984-12-06 | 1992-06-24 | セリンプロテアーゼインヒビターおよびこれを含有する医薬組成物 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP4166079A Expired - Lifetime JPH0717678B2 (ja) | 1984-12-06 | 1992-06-24 | セリンプロテアーゼインヒビターおよびこれを含有する医薬組成物 |
Country Status (2)
| Country | Link |
|---|---|
| JP (2) | JPS62501291A (OSRAM) |
| ZA (1) | ZA859362B (OSRAM) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3600571A1 (de) * | 1986-01-10 | 1987-08-06 | Gruenenthal Gmbh | Dna-sequenzen, die fuer proteine mit der biologischen aktivitaet der husi-typi-inhibitoren codieren, gentechnologische verfahren zur herstellung dieser proteine und diese proteine enthaltende arzneimittel |
| EP0804930A1 (en) * | 1994-03-23 | 1997-11-05 | Tokyo Tanabe Company Limited | Novel remedy for respiratory-tract viral disease |
| WO1997003694A1 (en) * | 1995-07-24 | 1997-02-06 | Tokyo Tanabe Company Limited | Remedy for viral diseases |
-
1985
- 1985-12-04 JP JP61500124A patent/JPS62501291A/ja active Granted
- 1985-12-06 ZA ZA859362A patent/ZA859362B/xx unknown
-
1992
- 1992-06-24 JP JP4166079A patent/JPH0717678B2/ja not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| ZA859362B (en) | 1987-03-25 |
| JPH0717678B2 (ja) | 1995-03-01 |
| JPS62501291A (ja) | 1987-05-21 |
| JPH05208999A (ja) | 1993-08-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US6287840B1 (en) | Irreversible cysteine protease inhibitors containing vinyl groups conjugated to electron withdrawing groups | |
| CA2030433A1 (en) | New isoquinoline- carboxamide amino acid derivatives useful for treatment of viral diseases | |
| US5444042A (en) | Method of treatment of neurodegeneration with calpain inhibitors | |
| HUP0400732A2 (hu) | Gyógyászatilag hatékony uridin-észterek | |
| WO2002018369A3 (en) | Peptidomimetic protease inhibitors | |
| IL129238A0 (en) | N-(aryl/heteroarylacetyl) amino acid esters pharmaceutical compositions comprising same and methods for inhibiting b-amyloid peptide release and/ or its synthesis by use of such compounds | |
| DE3482589D1 (de) | Retro-inverse analoga des bradykinin-potentialisierenden peptids bpp-5a und verfahren zu ihrer herstellung. | |
| CA2098609A1 (en) | Use of calpain inhibitors in the inhibition and treatment of neurodegeneration | |
| TR200101120T2 (tr) | Serin proteaz inhibitörü | |
| PL349334A1 (en) | Therapeutic agent for the suppression of snoring noises | |
| MY132473A (en) | Crystalline hydrochloride of (r)-(-)-2-<n-[4-(1,1- dioxido-3-oxo-2,3-dihydro-benzisothiazol-2-yl)-butyl]-aminomethyl>-chroman | |
| IL111674A0 (en) | 5,6-Dihydropyrone derivatives and pharmaceutical compositions containing them | |
| MY139203A (en) | Pharmaceutical composition | |
| DE60008399D1 (de) | Carbonsäuren und acylsulfonamide, solche verbindungen enthaltende zubereitungen und behandlungsmethoden | |
| IL111673A0 (en) | 5,6-Dihydropyrone derivatives and pharmaceutical compositions containing them | |
| TW200833321A (en) | Pharmaceutical composition for treating hypertension, diabetes mellitus and cardiovascular diseases | |
| ES8802468A1 (es) | Metodo de preparar medicamentos que incluyen un agente buscador de hueso y un inhibidor de anhidrasa carbonica, para impedir y curar enfermedades oseas. | |
| AU7270798A (en) | Antithrombotic agents | |
| JPH053880B2 (OSRAM) | ||
| WO2002064552A8 (en) | 1g(a)-AMINO-N-HYDROXY-ACETAMIDE DERIVATIVES | |
| CA2221793A1 (en) | Novel antibacterial protein | |
| RU94040865A (ru) | Производные пептида и их терапевтически приемлемые соли, способ их получения, фармацевтическая и косметическая композиция с антивирусной активностью | |
| EP1027051A4 (en) | ANTITHROMBOTIC AGENTS | |
| DE59005128D1 (de) | t-PA pro STABILISIERUNG. | |
| NZ256246A (en) | Serine leukocyte protease inhibitor, recombinant preparation thereof, and treatment of a retroviral infection |